ANI pharma, IDT Australia to commercialize US generic drugs

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Aug, 2015

Singapore: ANI Pharmaceuticals, a global specialty pharmaceutical company recently announced collaboration with IDT Australia a global generic manufacturer, to commercialize up to 18 previo...Read more

Brickell Biotech-Kaken Pharma to co-develop dermatology drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Apr, 2015

Brickell Biotech Inc., a US-based clinical-stage pharmaceutical company has signed an exclusive license and development agreement for BBI-4000 with Kaken Pharmaceutical Co. Ltd., a top-tier...Read more

Lupin scouts for acquisitions across the world

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2013

Singapore: Indian drug major Lupin Pharmaceuticals is set to expand its global footprint by scouting for acquisitions across the world. The company is looking at US, Japan, China and even t...Read more

US rheumatoid arthritis market to reach $9.3 bn by 2020'

Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2015

Singapore: US treatment market for rheumatoid arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9.3 billion by 2020, representing a compound annual growth rate (CAGR)...Read more

BioSpectrum announces the hits and misses of 2013

Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 02 Jan, 2014

Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase in the number of acquisitions and mergers (M&A), it also led to a ...Read more

Teva proposes to buy Mylan for $40.1 billion

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 22 Apr, 2015

Singapore: Israeli generic drug giant Teva pharmaceuticals made an unsolicited offer to buy US-based Mylan NV for about $40.1 billion, in the drug industry's largest takeover attempt this y...Read more

Teva's Potential $40 bn Mylan acquisition could transform generics space'

Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 27 Apr, 2015

Singapore: Teva Pharmaceutical Industries' recent $40.1 billion offer to purchase Netherlands-based Mylan, which is crucially contingent on Mylan not consummating its offer to acquire Irish...Read more

TB claims 74000 children each year: WHO

Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 02 Oct, 2013

Singapore: World Health Organization has launched "Roadmap for childhood TB: towards zero deaths", in an effort to prevent deaths of children from tuberculosis (TB) that claims nearly 74000...Read more

Boehringer, Lilly diabetes drug shows +ve results

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jun, 2013

Singapore: Boehringer Ingelheim and Eli Lilly and Company have presented their results from two randomized phase III clinical trials evaluating the 'efficacy and safety of linagliptin in As...Read more

Indian drugmakers shifting R&D to South East Asia

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

Singapore: Many leading Indian drug makers, that comprise a core part of the country's $1,000 bn worth pharmaceutical industry, are soon shifting their research and development operations a...Read more

Unlike FDA, Indian regulators finds no violations at Ranbaxy

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2013

Singapore: India's Drugs Controller General of India (DCGI) has said that under the country's Drugs and Cosmetics Act, it has found 'no major violations' at Ranbaxy's Mohali plant that has ...Read more

Pfizer, Hisun launch generics joint venture in China

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

Singapore: Pfizer and China's Zhejiang Hisun Pharmaceuticals, a leading Chinese pharmaceutical company, announced the launch of Hisun-Pfizer Pharmaceuticals, a joint venture formed between ...Read more

Teva launches generic of Abilify, antipsychotic drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 30 Apr, 2015

Singapore: Teva Pharmaceutical has launched the generic equivalent to Abilify, aripiprazole tablets, an atypical antipsychotic medication, are approved for the treatment of schizophrenia an...Read more

Sun's generic of Takeda ulcer drug gets FDA nod

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 16 Sep, 2013

Singapore: Indian pharmaceutical major, Sun Pharmaceutical Industries announced that the generic version of Prevacid by the company has received that final approval from the US FDA. The Am...Read more

Teva to pay $718 mn to apex tax body in Israel

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Nov, 2013

Singapore: Israel-based Teva Pharmaceutical is going to pay $718 million to Israel Tax Authority to pay for the release of trapped profits, settling tax assessments for the years 2005-07 an...Read more

Sandoz gets FDA nod for MS generic drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 17 Apr, 2015

Singapore: Sandoz, a Novartis company, has recieved USFDA approval of Glatopa, a first generic version of Teva's Copaxone (glatiramer acetate injection) for multiple sclerosis therapy. "Sa...Read more

Drug shortage forces FDA to approve cancer generic

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

Singapore: The US FDA has provided its approval for a generic version of cancer drug Doxil that has been facing shortage due to manufacturing deficiencies. This generic version of the drug...Read more

Hong Kong to host international TCM exhibition, conference

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Aug, 2013

Singapore: Hong Kong Trade Development Council (HKTDC) and Modernized Chinese Medicine International Association (MCMIA ) is organizing 12th International Conference and Exhibition of the M...Read more